Karen L. Bell

19.1k total citations
71 papers, 7.0k citations indexed

About

Karen L. Bell is a scholar working on Psychiatry and Mental health, Physiology and Neurology. According to data from OpenAlex, Karen L. Bell has authored 71 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Psychiatry and Mental health, 23 papers in Physiology and 12 papers in Neurology. Recurrent topics in Karen L. Bell's work include Dementia and Cognitive Impairment Research (35 papers), Alzheimer's disease research and treatments (21 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Karen L. Bell is often cited by papers focused on Dementia and Cognitive Impairment Research (35 papers), Alzheimer's disease research and treatments (21 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Karen L. Bell collaborates with scholars based in United States, United Kingdom and Canada. Karen L. Bell's co-authors include Yaakov Stern, Karen Marder, Diane M. Jacobs, Jason Brandt, Davangere P. Devanand, Mary Sano, Jennifer J. Manly, Gregory H. Pelton, Richard Mayeux and Marilyn Albert and has published in prestigious journals such as JAMA, American Journal of Psychiatry and Neurology.

In The Last Decade

Karen L. Bell

69 papers receiving 6.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen L. Bell United States 39 3.7k 2.6k 1.3k 860 783 71 7.0k
Robert S. Wilson United States 56 3.4k 0.9× 4.4k 1.7× 1.9k 1.5× 920 1.1× 1.2k 1.5× 135 11.6k
Angelo Bianchetti Italy 47 3.2k 0.9× 2.3k 0.9× 1.4k 1.1× 815 0.9× 639 0.8× 178 7.8k
Mikko P. Laakso Finland 45 3.4k 0.9× 2.7k 1.0× 2.8k 2.2× 704 0.8× 1.2k 1.5× 86 7.6k
JoAnn T. Tschanz United States 46 3.1k 0.8× 1.9k 0.7× 813 0.6× 304 0.4× 637 0.8× 128 6.0k
Tuomo Hänninen Finland 47 4.6k 1.3× 3.7k 1.4× 2.2k 1.7× 713 0.8× 1.4k 1.7× 148 9.1k
J. Jolles Netherlands 51 3.7k 1.0× 1.6k 0.6× 1.8k 1.5× 1.2k 1.4× 1.4k 1.8× 155 12.0k
Ronald Petersen United States 31 3.1k 0.9× 2.9k 1.1× 1.6k 1.3× 734 0.9× 1.0k 1.3× 67 6.4k
Andreas U. Monsch Switzerland 41 2.8k 0.8× 1.5k 0.6× 2.0k 1.6× 817 0.9× 543 0.7× 174 6.2k
Gregory H. Pelton United States 37 3.1k 0.8× 1.3k 0.5× 1.5k 1.2× 273 0.3× 680 0.9× 83 6.3k
Davangere P. Devanand United States 50 5.0k 1.4× 2.6k 1.0× 1.8k 1.4× 583 0.7× 1.3k 1.6× 204 9.7k

Countries citing papers authored by Karen L. Bell

Since Specialization
Citations

This map shows the geographic impact of Karen L. Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen L. Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen L. Bell more than expected).

Fields of papers citing papers by Karen L. Bell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen L. Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen L. Bell. The network helps show where Karen L. Bell may publish in the future.

Co-authorship network of co-authors of Karen L. Bell

This figure shows the co-authorship network connecting the top 25 collaborators of Karen L. Bell. A scholar is included among the top collaborators of Karen L. Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen L. Bell. Karen L. Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Devanand, D. P., Thomas Wısnıewskı, Qolamreza Razlighi, et al.. (2025). Valacyclovir Treatment of Early Symptomatic Alzheimer Disease. JAMA. 335(6). 511–511.
2.
Honig, Lawrence S., Radhika Jagannathan, Karen Marder, et al.. (2024). Clinical Use of Lecanemab at an Academic Medical Center. Alzheimer s & Dementia. 20(S8). 2 indexed citations
3.
Arnold, Steven E., Suzanne Hendrix, Jessie Nicodemus‐Johnson, et al.. (2024). Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 10(3). e12487–e12487. 5 indexed citations
4.
Devanand, Davangere P., Howard Andrews, William Charles Kreisl, et al.. (2020). Antiviral therapy: Valacyclovir Treatment of Alzheimer’s Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial. BMJ Open. 10(2). e032112–e032112. 52 indexed citations
5.
Gallun, Frederick J., Aaron R. Seitz, David A. Eddins, et al.. (2018). Development and validation of Portable Automated Rapid Testing (PART) measures for auditory research. Proceedings of meetings on acoustics. 33(1). 50002–50002. 34 indexed citations
6.
Sano, Mary, Karen L. Bell, Douglas Galasko, et al.. (2011). A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurology. 77(6). 556–563. 244 indexed citations
7.
Devanand, Davangere P., Xinhua Liu, Matthias H. Tabert, et al.. (2008). Combining Early Markers Strongly Predicts Conversion from Mild Cognitive Impairment to Alzheimer's Disease. Biological Psychiatry. 64(10). 871–879. 296 indexed citations
8.
Amatniek, Joan, W. Allen Hauser, Diane M. Jacobs, et al.. (2006). Incidence and Predictors of Seizures in Patients with Alzheimer's Disease. Epilepsia. 47(5). 867–872. 450 indexed citations
9.
Wright, Clinton B., Jean Paul Vonsattel, Karen L. Bell, & Lawrence S. Honig. (2006). Dementia with Cerebrovascular Disease. Science of Aging Knowledge Environment. 2006(10). dn1–dn1. 4 indexed citations
10.
Tabert, Matthias H., Jennifer J. Manly, Xinhua Liu, et al.. (2006). Neuropsychological Prediction of Conversion to Alzheimer Disease in Patients With Mild Cognitive Impairment. Archives of General Psychiatry. 63(8). 916–916. 486 indexed citations
11.
Pastore, Manuela, Steven Chin, Karen L. Bell, et al.. (2005). Creutzfeldt-Jakob Disease (CJD) with a Mutation at Codon 148 of Prion Protein Gene. American Journal Of Pathology. 167(6). 1729–1738. 29 indexed citations
12.
Manly, Jennifer J., et al.. (2003). The neuropsychological profiles of mild Alzheimer's disease and questionable dementia as compared to age-related cognitive decline. Journal of the International Neuropsychological Society. 9(5). 720–732. 55 indexed citations
13.
Aisen, Paul, Susan Egelko, Howard Andrews, et al.. (2003). A Pilot Study of Vitamins to Lower Plasma Homocysteine Levels in Alzheimer Disease. American Journal of Geriatric Psychiatry. 11(2). 246–249. 53 indexed citations
14.
Brickman, Adam M., Karen L. Bell, Karen Marder, et al.. (2002). Longitudinal Assessment of Patient Dependence in Alzheimer Disease. Archives of Neurology. 59(8). 1304–1304. 61 indexed citations
15.
Albert, Steven M., Diane M. Jacobs, Mary Sano, et al.. (2001). Longitudinal Study of Quality of Life in People with Advanced Alzheimer's Disease. American Journal of Geriatric Psychiatry. 9(2). 160–168. 49 indexed citations
16.
Mayeux, Richard, Ming‐Xin Tang, Diane M. Jacobs, et al.. (1999). Plasma amyloid ?-peptide 1-42 and incipient Alzheimer's disease. Annals of Neurology. 46(3). 412–416. 206 indexed citations
17.
Stern, Yaakov, X. Liu, M. Albert, et al.. (1996). Application of a Growth Curve Approach to Modeling the Progression of Alzheimer's Disease. The Journals of Gerontology Series A. 51A(4). M179–M184. 51 indexed citations
18.
Sano, Mary, D. P. Devanand, Marcus Richards, et al.. (1995). A Standardized Technique for Establishing Onset and Duration of Symptoms of Alzheimer's Disease. Archives of Neurology. 52(10). 961–966. 44 indexed citations
19.
Stern, Yaakov, M. Albert, Jason Brandt, et al.. (1994). Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease. Neurology. 44(12). 2300–2300. 195 indexed citations
20.
Stern, Yaakov, M. F. Folstein, Marilyn Albert, et al.. (1993). Multicenter Study of Predictors of Disease Course in Alzheimer Disease (the “Predictors Study”). I. Study Design, Cohort Description, and Intersite Comparisons. Alzheimer Disease & Associated Disorders. 7(1). 3–21. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert S. Wilson Breakdown of academic impact, for papers by Angelo Bianchetti Breakdown of academic impact, for papers by Mikko P. Laakso Breakdown of academic impact, for papers by JoAnn T. Tschanz Breakdown of academic impact, for papers by Tuomo Hänninen Breakdown of academic impact, for papers by J. Jolles Breakdown of academic impact, for papers by Ronald Petersen Breakdown of academic impact, for papers by Andreas U. Monsch Breakdown of academic impact, for papers by Gregory H. Pelton Breakdown of academic impact, for papers by Davangere P. Devanand
Rankless by CCL
2026